Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature

被引：2
|
作者：
Gautret, Philippe [1 ,2 ]
Van Thuan Hoang [1 ,2 ,3 ]
Honore, Stephane [4 ,5 ]
Roussel, Yanis [1 ,6 ]
Million, Matthieu [1 ,6 ]
Lagier, Jean-Christophe [1 ,6 ]
Raoult, Didier [1 ,6 ]
机构：
[1] IHU Mediterranee Infect, Marseille, France
[2] Aix Marseille Univ, IRD, AP HM, SSA,VITROME, Marseille, France
[3] Thai Binh Univ Med & Pharm, Thai Binh, Vietnam
[4] Hop La Timone, AP HM, Serv Pharm, Marseille, France
[5] Aix Marseille Univ, Lab Pharmacie Clin, Marseille, France
[6] Aix Marseille Univ, IRD, APHM, MEPHI, Marseille, France
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2021年 / 57卷 / 01期
关键词：
D O I：
10.1016/j.ijantimicag.2020.106241
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Response to: "Risks of hydroxychloroquine use for COVID-19 prophylaxis"
    Grant-Kels, Jane M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : E75 - E76
  • [42] Evaluation of Corrected QT Intervals of 74 COVID-19 Patients Treated with Hydroxychloroquine in Combination with or without Azithromycin and/or Favipiravir
    Uyaroglu, Oguz Abdullah
    Sener, Yusuf Ziya
    Ozdede, Murat
    Basaran, Nursel Calik
    Ozisik, Lale
    Sahin, Taha Koray
    Canpolat, Ugur
    Inkaya, Ahmet Cagkan
    Yorgun, Hikmet
    Guven, Gulay Sain
    Aytemir, Kudret
    EUROPEAN JOURNAL OF THERAPEUTICS, 2021, 27 (04): : 311 - 317
  • [43] No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
    Molina, J. M.
    Delaugerre, C.
    Le Goff, J.
    Mela-Lima, B.
    Ponscarme, D.
    Goldwirt, L.
    de Castro, N.
    MEDECINE ET MALADIES INFECTIEUSES, 2020, 50 (04): : 384 - 384
  • [44] A Bayesian reanalysis of the effects of hydroxychloroquine and azithromycin on viral carriage in patients with COVID-19
    Hulme, Oliver James
    Wagenmakers, Eric-Jan
    Damkier, Per
    Madelung, Christopher Fugl
    Siebner, Hartwig Roman
    Helweg-Larsen, Jannik
    Gronau, Quentin F.
    Benfield, Thomas Lars
    Madsen, Kristoffer Hougaard
    PLOS ONE, 2021, 16 (02):
  • [45] THE EFFECT OF TREATMENT WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN ON THE CORRECTED QT INTERVAL IN PATIENTS WITH COVID-19
    Batemarco, Thomas
    Manongi, Ngoda
    Sunkaraneni, Sushant
    Vapnik, Joshua
    Kim, JoonHyuk
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 2154 - 2154
  • [46] Adverse Cardiac Events Among the Patients Using Hydroxychloroquine and Azithromycin in COVID-19
    Dural, Ibrahim Etem
    Nadir, Yasemin
    INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2020, 2 (03): : 158 - 162
  • [47] No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France"
    Lebeaux, David
    Revest, Matthieu
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 36
  • [48] Response to the editorial "COVID-19 in patients with cardiovascular diseases". Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes
    Funck-Brentano, Christian
    Salem, Joe-Elie
    Nguyen, Lee S.
    Drici, Milou-Daniel
    Roden, Dan M.
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2020, 113 (05) : 367 - 368
  • [49] Psychiatric implications of the use of hydroxychloroquine in COVID-19 patients
    Rani, Seema
    Grover, Sandeep
    Mehra, Aseem
    Sahoo, Swapnajeet
    INDIAN JOURNAL OF PHARMACOLOGY, 2020, 52 (03) : 229 - 231
  • [50] Hydroxychloroquine versus hydroxychloroquine-azithromycin combination therapy on QT interval prolongation of COVID-19 patients: a systematic review and meta-analysis
    Pinandito, Yohanes Krisnantyo Adi
    Salfi, Qorina Nadya
    Putri, Kezia Warokka
    Caesario, Jefferson
    Rahmadi, I. Gusti Hanif
    Suhargo, Melisa
    Rafikasari, Aulia
    Julario, Rerdin
    Prajitno, Subur
    COR ET VASA, 2021, 63 (04) : 475 - 480
12345